NO20015257D0 - Farmasöytisk sammensetning for å hindre, behandle eller utviklingsinhibere enkel retinopati og preproliferativ retinopati - Google Patents

Farmasöytisk sammensetning for å hindre, behandle eller utviklingsinhibere enkel retinopati og preproliferativ retinopati

Info

Publication number
NO20015257D0
NO20015257D0 NO20015257A NO20015257A NO20015257D0 NO 20015257 D0 NO20015257 D0 NO 20015257D0 NO 20015257 A NO20015257 A NO 20015257A NO 20015257 A NO20015257 A NO 20015257A NO 20015257 D0 NO20015257 D0 NO 20015257D0
Authority
NO
Norway
Prior art keywords
retinopathy
pharmaceutical composition
developmentally
treat
prevent
Prior art date
Application number
NO20015257A
Other languages
English (en)
Other versions
NO327446B1 (no
NO20015257L (no
Inventor
Shizue Nakagawa
Yasutaka Nagisha
Hitoshi Ikeda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20015257D0 publication Critical patent/NO20015257D0/no
Publication of NO20015257L publication Critical patent/NO20015257L/no
Publication of NO327446B1 publication Critical patent/NO327446B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20015257A 1999-04-28 2001-10-26 Anvendelse av en forbindelse som har angiotensin II antagonistisk aktivitet, et prodrug derav eller et salt derav. NO327446B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28
PCT/JP2000/002766 WO2000066161A1 (fr) 1999-04-28 2000-04-27 Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante

Publications (3)

Publication Number Publication Date
NO20015257D0 true NO20015257D0 (no) 2001-10-26
NO20015257L NO20015257L (no) 2001-10-26
NO327446B1 NO327446B1 (no) 2009-06-29

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015257A NO327446B1 (no) 1999-04-28 2001-10-26 Anvendelse av en forbindelse som har angiotensin II antagonistisk aktivitet, et prodrug derav eller et salt derav.

Country Status (23)

Country Link
US (2) US7064141B1 (no)
EP (1) EP1197223B1 (no)
KR (1) KR100865059B1 (no)
CN (1) CN1172719C (no)
AT (1) ATE289204T1 (no)
AU (1) AU774799B2 (no)
BR (1) BR0010084A (no)
CA (1) CA2371554C (no)
CZ (1) CZ301913B6 (no)
DE (1) DE60018186T2 (no)
DK (1) DK1197223T3 (no)
ES (1) ES2233362T3 (no)
HU (1) HU226948B1 (no)
MX (1) MXPA01010923A (no)
NO (1) NO327446B1 (no)
NZ (1) NZ514855A (no)
PL (1) PL196895B1 (no)
PT (1) PT1197223E (no)
RU (1) RU2239454C2 (no)
SI (1) SI1197223T1 (no)
SK (1) SK286859B6 (no)
WO (1) WO2000066161A1 (no)
ZA (1) ZA200108527B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
US20050032854A1 (en) * 2001-12-03 2005-02-10 Kiminori Kawahara Insulin resistance improving agents
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
EP1614428A4 (en) * 2003-04-15 2010-01-06 Sankyo Co MEDICAMENT FOR THE PREVENTION OR TREATMENT OF ANGIOGENIC OCULAR DISEASES
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
WO2006024092A1 (en) * 2004-08-31 2006-03-09 Newsouth Innovations Pty Limited Vegf inhibition
MX366895B (es) * 2004-11-05 2019-07-30 Boehringer Ingelheim Int Gmbh Star Comprimido bicapa que comprende telmisartán y amlodipina.
PL1872783T3 (pl) * 2005-04-21 2012-05-31 Santen Pharmaceutical Co Ltd Środek leczniczy w schorzeniach rogówkowo-spojówkowych
US20090270474A1 (en) * 2005-12-06 2009-10-29 Keiichi Shibagaki Therapeutic Agent for Keratoconjunctival Disorder
TWI415634B (zh) * 2007-03-28 2013-11-21 Takeda Pharmaceutical 固態醫藥組成物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4201554A1 (de) 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9110635D0 (en) 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
ZA931063B (en) 1992-02-17 1993-09-23 Ciba Geigy Treatment of glaucoma.
GB9223860D0 (en) * 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
CA2181461A1 (en) * 1994-02-08 1995-08-17 Alica Huxley Treatment of normotensive glaucoma with angiotensin ii antagonists
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
CZ293345B6 (cs) * 1996-03-29 2004-04-14 Smithkline Beecham Corporation Dihydrát monomethansulfonatu kyseliny (E)-alfa-[2-n-butyl-1-[(4-karboxyfenyl)methyl]-1H-imidazol-5-yl]methylen-2-thiofenpropionové
SI0914158T2 (sl) * 1996-04-05 2006-04-30 Takeda Chemical Industries Ltd Farmacevtska kombinacija, ki vsebuje spojino z angiotenzin II-antagonisticno aktivnostjo in spojino, ki povecuje inzulinsko obcutljivost
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6262102B1 (en) * 1997-06-27 2001-07-17 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
NZ502644A (en) * 1997-08-06 2002-03-01 Smithkline Beecham Corp Eprosartan arginyl charge-neutralization-complex useful for treating diseases where blockade of the angiotensin II receptor is indicated
ZA991706B (en) 1998-03-04 2000-10-03 Takeda Chemical Industries Ltd Sustained-release preparation for Aii Antagonist, production and use thereof.
CA2336822C (en) 1998-07-10 2009-11-17 Novartis Ag Method of treatment and pharmaceutical composition
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
BR0010084A (pt) 2002-01-15
AU774799B2 (en) 2004-07-08
WO2000066161A1 (fr) 2000-11-09
ATE289204T1 (de) 2005-03-15
CZ20013804A3 (cs) 2002-04-17
NO327446B1 (no) 2009-06-29
CA2371554A1 (en) 2000-11-09
RU2239454C2 (ru) 2004-11-10
CN1172719C (zh) 2004-10-27
EP1197223A4 (en) 2003-10-29
CA2371554C (en) 2009-06-09
DK1197223T3 (da) 2005-05-30
EP1197223A1 (en) 2002-04-17
ES2233362T3 (es) 2005-06-16
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
DE60018186T2 (de) 2005-12-29
CN1348385A (zh) 2002-05-08
HUP0200890A2 (hu) 2002-11-28
KR100865059B1 (ko) 2008-10-23
SI1197223T1 (no) 2005-08-31
PL196895B1 (pl) 2008-02-29
ZA200108527B (en) 2002-10-17
PL350554A1 (en) 2002-12-16
KR20020015315A (ko) 2002-02-27
AU4143400A (en) 2000-11-17
HU226948B1 (en) 2010-03-29
MXPA01010923A (es) 2002-06-21
DE60018186D1 (de) 2005-03-24
EP1197223B1 (en) 2005-02-16
PT1197223E (pt) 2005-04-29
US20060189669A1 (en) 2006-08-24
CZ301913B6 (cs) 2010-07-28
US7064141B1 (en) 2006-06-20
NO20015257L (no) 2001-10-26
HUP0200890A3 (en) 2002-12-28
NZ514855A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
GB9801690D0 (en) Therapeutic agents
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
TR199902033T2 (xx) Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�.
PT1214936E (pt) Utilizacao de derivados de tiazolidina ou pirrolidina de aminoacidos como agentes anti-hiperglicemicos
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
DE60131138D1 (de) Antibakterielle mittel
NO20015257L (no) Farmasöytisk sammensetning for å hindre, behandle eller utviklingsinhibere enkel retinopati og preproliferativ retinopati
ATE387215T1 (de) Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff
BR9911781B1 (pt) iluminador para terapia fotodinámica.
BR0109703A (pt) Derivados de piperazina
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
BR0113161A (pt) Arilóxi piperidinas não imidazóis
DK0624583T3 (da) Substituerede pyridylmethylpyridoner som angiotensin II-antagonister
SE0104248D0 (sv) Method of treatment
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
BR0316085A (pt) Substâcias microbicidas
TR200201245T2 (tr) Kanser tedavisi için onkolitik kombinasyonlar.
DE60008935D1 (de) Pyridinsulfonylharnstoffderivate mit herbizider wirkung
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
NZ331484A (en) Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases
ZA200308147B (en) Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals.
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees